Assenagon Asset Management S.A. Regenxbio Inc. Transaction History

Assenagon Asset Management S.A.

$54.8 Billion
Q1 2025

A detailed history of Assenagon Asset Management S.A. transactions in Regenxbio Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 573,173 shares of RGNX stock, worth $4.95 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

573,173

Previous 856,572 33.09%

Holding current value

$4.95 Million

Previous $6.62 Million 38.11%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 15, 2025	SELL	$5.92 - $8.7 $1.68 Million - $2.47 Million	-283,399 Reduced 33.09%	573,173 $4.1 Million
Q4 2024 Jan 14, 2025	BUY	$7.23 - $11.56 $2.15 Million - $3.43 Million	296,700 Added 52.99%	856,572 $6.62 Million
Q3 2024 Oct 23, 2024	SELL	$10.49 - $14.39 $2.69 Million - $3.69 Million	-256,512 Reduced 31.42%	559,872 $5.87 Million
Q2 2024 Jul 18, 2024	BUY	$11.51 - $21.53 $6.78 Million - $12.7 Million	588,773 Added 258.68%	816,384 $9.55 Million
Q1 2024 Apr 24, 2024	BUY	$12.17 - $24.61 $1.47 Million - $2.98 Million	120,929 Added 113.35%	227,611 $4.8 Million
Q4 2023 Jan 17, 2024	BUY	$12.89 - $20.82 $1.38 Million - $2.22 Million	106,682 New	106,682 $1.91 Million
Q1 2022 Apr 25, 2022	BUY	$24.62 - $34.31 $2.1 Million - $2.93 Million	85,438 Added 30.77%	363,138 $12.1 Million
Q4 2021 Feb 01, 2022	BUY	$30.19 - $40.28 $4.22 Million - $5.64 Million	139,947 Added 101.59%	277,700 $9.08 Million
Q3 2021 Oct 19, 2021	BUY	$29.09 - $45.68 $4.01 Million - $6.29 Million	137,753 New	137,753 $5.78 Million
Q3 2020 Oct 07, 2020	SELL	$27.01 - $40.26 $1.25 Million - $1.86 Million	-46,292 Closed	0 $0
Q2 2020 Jul 21, 2020	SELL	$27.75 - $43.44 $588,300 - $920,928	-21,200 Reduced 31.41%	46,292 $1.71 Million
Q1 2020 Apr 17, 2020	BUY	$21.5 - $54.2 $1.45 Million - $3.66 Million	67,492 New	67,492 $2.19 Million

Others Institutions Holding RGNX

# of Institutions

182

Shares Held

45.3M

Call Options Held

64.9K

Put Options Held

103K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $374M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Account

Assenagon Asset Management S.A. Regenxbio Inc. Transaction History